Amgen Inc (AMGN)

Days of sales outstanding (DSO)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
DSO	days	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —

Based on the provided data, the Days of Sales Outstanding (DSO) for Amgen Inc is not available for the financial periods spanning from March 31, 2020, to December 31, 2024. DSO is a financial ratio that measures the number of days it takes for a company to collect its accounts receivable from sales. The absence of specific DSO figures indicates that the information regarding the average collection period for Amgen Inc's sales is not disclosed or calculated for the stated periods.

DSO is a critical metric in assessing a company's efficiency in managing its accounts receivable and cash flows. A lower DSO value typically indicates a faster collection cycle, which is favorable for liquidity and working capital management. On the other hand, a higher DSO may signal potential issues related to credit policies, customer payment delays, or collection efficiency.

In the absence of specific DSO values for Amgen Inc, further analysis or additional data would be necessary to evaluate the company's receivables management practices and their impact on overall financial performance. Investors and financial analysts often consider DSO trends over time to identify any significant changes in the company's collection efficiency and potential risks associated with accounts receivable management.